Frank L Meyskens

This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University of California, The University of Arizona, Northwestern University. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank L Meyskens. Retrieved from https://idiyas.com/inventor/frank-l-meyskens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 62(Granted Patents)

Company Filing History:

6 out of 16,025

University of California

patents

3 out of 1,060

The University of Arizona

patents

2 out of 2,217

Northwestern University

patents

4. 1 out of 1

Cognis Australia Pty., Ltd.

patent

5. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9980924 - Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin (2018-05-29),

2. 9937141 - Carcinoma diagnosis and treatment, based on ODC1 genotype (2018-04-10),

3. 9121852 - [object Object] (2015-09-01),

4. 9090589 - Specific nNOS inhibitors for the therapy and prevention of human melanoma (2015-07-28),

5. 8642282 - Inhibitors of nitric oxide synthase for treatment of melanoma (2014-02-04),

6. 8329636 - Carcinoma diagnosis and treatment, based on ODC1 genotype (2012-12-11),

7. 6428816 - Carotenoid agent for inhibiting the conversion of epithelial cells to tumors (2002-08-06),

8. 6258845 - DFMO and sulindac combination in cancer chemoprevention (2001-07-10),

Title: Frank L Meyskens: Innovator in Dermatological and Oncological Solutions

Introduction

Frank L Meyskens is a prominent inventor based in Irvine, CA (US), known for his significant contributions to dermatology and oncology. With a total of 8 patents, he has developed innovative solutions aimed at improving skin health and cancer treatment.

Latest Patents

Meyskens' latest patents include groundbreaking work on topical pterostilbene compositions designed to treat UV-induced loss of barrier function in skin. This invention provides a chemoprotective method that utilizes pterostilbene to prevent damage caused by ultraviolet (UV) light. Additionally, he has developed pharmaceutical and nutraceutical compositions containing pterostilbene, which are suitable for administration to individuals to prevent subsequent UV-mediated skin damage. Another notable patent focuses on carcinoma diagnosis and treatment based on the ODC1 genotype. This invention offers methods and kits for predicting colorectal cancer patient survival and selecting appropriate treatment options based on genetic markers.

Career Highlights

Throughout his career, Frank L Meyskens has worked with esteemed institutions such as the University of California and the University of Arizona. His research has significantly advanced the understanding of skin health and cancer treatment methodologies.

Collaborations

Meyskens has collaborated with notable colleagues, including Eugene W Gerner and Jason A Zell, contributing to the development of innovative solutions in his field.

Conclusion

Frank L Meyskens stands out as a key figure in the realms of dermatology and oncology, with a focus on innovative treatments that address critical health issues. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.